I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 4 studies | 25% ± 4% | |
| plasma cell | 4 studies | 23% ± 5% | |
| oligodendrocyte | 4 studies | 19% ± 3% | |
| cardiac muscle cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 4 studies | 25% ± 4% | |
| plasma cell | 4 studies | 23% ± 5% | |
| oligodendrocyte | 4 studies | 19% ± 3% | |
| cardiac muscle cell | 3 studies | 17% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 9757.63 | 2639 / 2642 | 93% | 18.02 | 656 / 705 |
| ovary | 94% | 1439.46 | 169 / 180 | 95% | 8.30 | 407 / 430 |
| prostate | 71% | 716.67 | 175 / 245 | 100% | 19.16 | 502 / 502 |
| pancreas | 100% | 5710.07 | 328 / 328 | 69% | 5.07 | 123 / 178 |
| stomach | 95% | 1839.93 | 340 / 359 | 72% | 3.41 | 205 / 286 |
| liver | 90% | 1347.88 | 203 / 226 | 75% | 5.70 | 305 / 406 |
| kidney | 75% | 871.54 | 67 / 89 | 86% | 11.43 | 778 / 901 |
| uterus | 65% | 665.49 | 110 / 170 | 86% | 6.10 | 397 / 459 |
| bladder | 67% | 564.86 | 14 / 21 | 84% | 5.58 | 421 / 504 |
| thymus | 56% | 497.87 | 367 / 653 | 94% | 7.28 | 567 / 605 |
| esophagus | 83% | 991.38 | 1201 / 1445 | 66% | 3.75 | 121 / 183 |
| intestine | 64% | 589.77 | 621 / 966 | 81% | 4.03 | 427 / 527 |
| breast | 46% | 415.95 | 213 / 459 | 87% | 6.32 | 971 / 1118 |
| skin | 70% | 1287.82 | 1275 / 1809 | 44% | 1.83 | 209 / 472 |
| lung | 22% | 177.81 | 125 / 578 | 86% | 6.00 | 993 / 1155 |
| muscle | 99% | 4362.26 | 797 / 803 | 0% | 0 | 0 / 0 |
| heart | 87% | 2663.74 | 750 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 87% | 5.79 | 39 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 2.33 | 16 / 29 |
| adrenal gland | 2% | 12.55 | 5 / 258 | 41% | 1.46 | 94 / 230 |
| blood vessel | 32% | 284.69 | 425 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 31% | 1.25 | 25 / 80 |
| adipose | 23% | 190.51 | 278 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 6% | 43.89 | 15 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 2% | 14.56 | 18 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045947 | Biological process | negative regulation of translational initiation |
| GO_0017148 | Biological process | negative regulation of translation |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0030371 | Molecular function | translation repressor activity |
| GO_0000900 | Molecular function | mRNA regulatory element binding translation repressor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PAIP2B |
| Protein name | Polyadenylate-binding protein-interacting protein 2B (PABP-interacting protein 2B) (PAIP-2B) (Poly(A)-binding protein-interacting protein 2B) |
| Synonyms | KIAA1155 |
| Description | FUNCTION: Inhibits translation of capped and polyadenylated mRNAs by displacing PABPC1 from the poly(A) tail. . |
| Accessions | Q9ULR5 ENST00000244221.9 |
